First Hawaiian Bank raised its position in Envista Holdings Corporation (NYSE:NVST - Free Report) by 47.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,597 shares of the company's stock after purchasing an additional 15,312 shares during the quarter. First Hawaiian Bank's holdings in Envista were worth $822,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Strs Ohio acquired a new stake in shares of Envista in the 1st quarter valued at about $1,433,000. Bayforest Capital Ltd raised its stake in shares of Envista by 956.8% in the 1st quarter. Bayforest Capital Ltd now owns 42,982 shares of the company's stock valued at $742,000 after purchasing an additional 38,915 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company's stock valued at $9,821,000 after purchasing an additional 76,246 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company's stock valued at $10,859,000 after purchasing an additional 177,630 shares during the period. Finally, Sepio Capital LP raised its stake in shares of Envista by 5.8% in the 1st quarter. Sepio Capital LP now owns 41,040 shares of the company's stock valued at $708,000 after purchasing an additional 2,240 shares during the period.
Wall Street Analyst Weigh In
Several research firms have issued reports on NVST. Wells Fargo & Company lifted their price target on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. Zacks Research downgraded Envista from a "strong-buy" rating to a "hold" rating in a research note on Monday. Stifel Nicolaus lifted their target price on Envista from $24.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, August 1st. UBS Group lifted their target price on Envista from $18.00 to $22.00 and gave the company a "neutral" rating in a research report on Tuesday, July 29th. Finally, Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 27th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.92.
Check Out Our Latest Stock Report on Envista
Envista Stock Performance
NYSE NVST traded down $0.12 during trading on Friday, reaching $20.91. 4,326,082 shares of the company's stock were exchanged, compared to its average volume of 1,561,417. The business has a 50 day moving average price of $20.62 and a 200-day moving average price of $18.63. The stock has a market capitalization of $3.47 billion, a P/E ratio of 65.35, a PEG ratio of 1.13 and a beta of 0.99. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.44 and a quick ratio of 2.08. Envista Holdings Corporation has a fifty-two week low of $14.22 and a fifty-two week high of $23.00.
Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The firm had revenue of $682.10 million for the quarter, compared to the consensus estimate of $638.21 million. Envista had a return on equity of 4.84% and a net margin of 2.11%.The business's revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.11 earnings per share. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. Sell-side analysts forecast that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.
Envista Company Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
See Also

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.